BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38313018)

  • 1. Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases.
    Li Z; Lv H; Zhang F; Zhu Z; Guo Q; Wang M; Huang C; Guo L; Meng F; Tian Z
    PeerJ; 2024; 12():e16808. PubMed ID: 38313018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM.
    Wang X; Gong Y; Yao J; Chen Y; Li Y; Zeng Z; Lu Y; Song L
    Front Oncol; 2020; 10():614430. PubMed ID: 33552986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and immune characteristics of multiple primary lung cancers and lung metastases.
    Yang R; Li P; Wang D; Wang L; Yin J; Yu B; Li M; Wang S; Wang Y
    Thorac Cancer; 2021 Oct; 12(19):2544-2550. PubMed ID: 34510768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
    Ezer N; Wang H; Corredor AG; Fiset PO; Baig A; van Kempen LC; Chong G; Issac MSM; Fraser R; Spatz A; Riviere JB; Broët P; Spicer J; Camilleri-Broët S
    Cancer Treat Res Commun; 2021; 29():100484. PubMed ID: 34773797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive algorithm to distinguish between MPLC and IPM in multiple lung tumors patients.
    Shao J; Wang C; Li J; Song L; Li L; Tian P; Li W
    Ann Transl Med; 2020 Sep; 8(18):1137. PubMed ID: 33240986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic features and application value of next generation sequencing in the diagnosis of synchronous multifocal lung adenocarcinoma.
    Chen X; Lu J; Wu Y; Jiang X; Gu Y; Li Y; Zhao H; Jin M
    Oncol Lett; 2020 Sep; 20(3):2829-2839. PubMed ID: 32782601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients.
    Liang Z; Zeng G; Wan W; Deng B; Chen C; Li F; Lin G; Lin Y; Lin H; Mo G; Miao H
    Discov Med; 2023 Apr; 35(175):131-143. PubMed ID: 37188510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis.
    Liu J; Mao G; Li Y; Tao L; Wang W; Peng X; Wang J; Li X; Luan X; Luo R; Huang T; Zhang J; Xu M; Chen S; Wu D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2359-2367. PubMed ID: 32333141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characteristics of early-stage multiple primary and independent primary lung adenocarcinoma patients.
    Li P; Yang R; Wang D; Wang L; Wang S; Liu C; Li J; Li L; Liu C; Tong Y; Wang Y
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e420-e426. PubMed ID: 35098658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: targeted sequencing improves the diagnosis of multiple synchronous lung cancers.
    Ba Y; Li H; Zhu J; Wang H; Lv H; Guo C; Sun R; Zheng J; Meng L; Shi S
    Transl Lung Cancer Res; 2023 Apr; 12(4):933-939. PubMed ID: 37197634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
    Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
    Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations.
    Hu Y; Ren S; Chen C; Liang Q; Yu F; Liu W
    Thorac Cancer; 2020 Jul; 11(7):2018-2022. PubMed ID: 32415761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and transcriptomic significance of multiple primary lung cancers detected by next-generation sequencing in clinical settings.
    Yao M; Chen H; Chen Z; Wang Y; Shi D; Wu D; Li W; Huang J; Chen G; Zheng Q; Ye Z; Zheng C; Yang Y
    Carcinogenesis; 2024 Jun; 45(6):387-398. PubMed ID: 38693810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data.
    Pei G; Sun K; Yang Y; Wang S; Li M; Ma X; Wang H; Chen L; Qin J; Cao S; Liu J; Huang Y
    Front Oncol; 2024; 14():1388575. PubMed ID: 38764572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple primary lung cancer: A literature review.
    Romaszko AM; Doboszyńska A
    Adv Clin Exp Med; 2018 May; 27(5):725-730. PubMed ID: 29790681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic Investigation.
    Roepman P; Ten Heuvel A; Scheidel KC; Sprong T; Heideman DAM; Seldenrijk KA; Herder GJM; Kummer JA
    J Mol Diagn; 2018 Jul; 20(4):436-445. PubMed ID: 29625247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis.
    Pei G; Li M; Min X; Liu Q; Li D; Yang Y; Wang S; Wang X; Wang H; Cheng H; Cao S; Huang Y
    Front Oncol; 2021; 11():653988. PubMed ID: 34109114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
    Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
    J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal Origin Evaluated by Trunk and Branching Drivers and Prevalence of Mutations in Multiple Lung Tumor Nodules.
    Rodriguez EF; Tseng LH; De Marchi F; Haung J; Belchis D; Xian R; Gocke CD; Eshleman JR; Illei PB; Lin MT
    Mol Diagn Ther; 2020 Aug; 24(4):461-472. PubMed ID: 32504414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
    Takahashi Y; Shien K; Tomida S; Oda S; Matsubara T; Sato H; Suzawa K; Kurihara E; Ogoshi Y; Namba K; Yoshioka T; Torigoe H; Yamamoto H; Soh J; Toyooka S
    Cancer Sci; 2018 Nov; 109(11):3634-3642. PubMed ID: 30216592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.